Velan (VLN) Q2 2027 earnings summary

Executive summary

• Transition quarter: sales fell 14.9% YoY to $57.5M as shipment timing and execution constraints weighed on results; demand in core nuclear, defense and energy markets remained solid.

• Priorities include rebuilding the foundation for profitable growth through execution, cost discipline, working-capital actions and larger core-market opportunities.

Financial highlights

• Q2 sales were $57.5M, down 14.9% from $67.6M; bookings were $47.9M versus $65.2M YoY.

• Gross profit was $12.6M, or 21.9% of sales, versus $15.7M and 23.2% a year earlier; lower volume, project mix and tariffs pressured results.

• Net loss was $15.1M ($0.70 per share), including $14.9M in transaction costs; adjusted net loss was $6.2M ($0.29 per share) and adjusted EBITDA was a loss of $0.713M.

• H1 sales were $115.4M, down 17.5% YoY; adjusted net loss was $13.1M and adjusted EBITDA was a loss of $2.8M.

Outlook and guidance

• Near-term orders are expected to remain mixed by region; some larger nuclear, defense and project opportunities at varying qualification stages may convert in the near term.

• H2 priorities include growing bookings and optimizing costs, with cost actions intended to protect margins.

• Favorable long-term fundamentals and a $262.5M backlog support the outlook.